88.1% sensitivity among ensemble-ascertained clinically relevant fusions
Arriba sensitivity among ensemble-ascertained clinically relevant fusions
- Tested configuration
- Arriba
- Protocol
- NCH clinically relevant fusion ascertainment
- Dataset
- Nationwide Children hospital pediatric cancer/hematologic cohort
- Procedure
- name: NCH clinically relevant fusion ascertainment; proposed id: amp-oncology-rna-20261007-protocol-enfusion-nch-clinical; version: 2021 article Table 1
- Evaluation
- Arriba NCH clinical-ascertainment evaluation
- Coverage
- scored: unreported; eligible: unreported
- Uncertainty
- Not reported
- Evidence
- Independent external evaluation · source checkedDiscovery of clinically relevant fusions in pediatric cancer · Table 1, Arriba row, Sensitivity column (JATS Tab1)
A source-checked result verifies the numerical transcription, not every model or protocol detail. Evaluation metadata: source checked. Source checked does not mean independently reproduced.
Reproduction
- Split
- Not reported
- Adaptation
- Not reported
- Scoring implementation
- Not reported
No execution recipe has been verified for this exact configuration and evaluation. A benchmark's general instructions may use different inputs, splits or model settings.
Reproducing this published result requires matching its model configuration, data, split and scorer. Source checking or a successful smoke test does not establish score reproduction.
Evidence
Source checking verifies the cited claim or transcription. It does not establish independent reproduction.
Evidence table
Inspect claims, sources and review details
Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.
One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.
1 evidence row matching the loaded filters
| Property and statement | Original source and location | Review and provenance |
|---|---|---|
| Reported result 88.1% Individual claims | Discovery of clinically relevant fusions in pediatric cancer Table 1, Arriba row, Sensitivity column (JATS Tab1) Version: Europe PMC fullTextXML retrieved 2026-10-07T12:25:20.810843+00:00 | source checked automated source review · 2026-10-07T13:38:59Z independent paper Audit detailsBounded transcription of a Codex-checked primary-source cell. No independent experimental reproduction or qualified human scientific review. Field: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Sources and history
View linked audit checks and correction history
Release 2026-10-07-1448159e6a81 · Record review: source checked
1 source records and release history
- Discovery of clinically relevant fusions in pediatric cancer · Original source · Europe PMC fullTextXML retrieved 2026-10-07T12:25:20.810843+00:00
Technical metadata and extraction receipts
Stable ID: amp-oncology-rna-20261007-nch-result-arriba-sensitivity-among-ensemble-ascertained-clinically-relevant-fusions
- metric
- sensitivity among ensemble-ascertained clinically relevant fusions
- metric direction
- higher
- missing metadata
- None recorded
- numeric value
- 88.1
- printed value
- 88.1%
- review
- method: automated_source_review; notes: Bounded transcription of a Codex-checked primary-source cell. No independent experimental reproduction or qualified human scientific review.; reviewed at: 2026-10-07T13:38:59Z; reviewer: Claude Sonnet AMP-integration worker, bounded transcription of Codex-checked primary values (workbench/amp-supervision/primary-review.md, integration-review-corrections.md); pending qualified human scientific review
- source locator
- Table 1, Arriba row, Sensitivity column (JATS Tab1)
- uncertainty
- Not reported
- unit
- %
Related records
- evaluation: Arriba NCH clinical-ascertainment evaluation